FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
Biotechnology | Diagnostics | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Vaccines containing cell-cultured virus became available
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
FDA expanded use of Prevnar 13 vaccine to include people ages 50 and older
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Vaccine
Novel Reassortant Highly Pathogenic Avian Influenza (H5N5) Viruses in Domestic Ducks, China
On Jun. 11, 2011, scientists in China reported the isolation of 2 novel reassortant highly pathogenic avian influenza…
WHO declared end to 2009 H1N1 influenza pandemic
On Aug. 10, 2010, WHO Director-General Dr Margaret Chan announced that the H1N1 influenza virus had moved into…
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
Biotechnology | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Vaccine | WHO
Bill and Melinda Gates Foundation Pledged $10 Billion in Call for Decade of Vaccines
On Jan. 29, 2010, the Bill and Melinda Gates announced that their foundation will commit $10 billion over…
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
CDC recommended pneumococcal vaccination to help prevent secondary infections
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
FDA approved four vaccines against the 2009 H1N1 influenza virus
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
ACIP issued recommendations on the use of H1N1 influenza vaccines
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
HHS announced advanced development contract for new way to make flu vaccine
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
WHO declared world at the start of 2009 influenza pandemic
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General WHO, declared world now at the start of 2009…
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
A novel influenza A (H1N1)pdm09 virus was detected first in the U.S. before spreading worldwide
On Apr. 15, 2009, a novel influenza A virus (then referred to as ‘swine origin influenza A virus’)…
Biotechnology | CDC | Diagnostics | Influenza | Life Science News | NIH | Therapeutics
CDC began a complex and multi-faceted response to the H1N1 pandemic
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…
Physicians used point of care rapid immunoassay tests to provide influenza results during H1N1 pandemic
In Apr. 2009, physicians used point of care rapid immunoassay tests to provide influenza results within 15 minutes…
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
Drs. Judith James and Linda Thompson at the OMRF helped develop a H1N1 or ‘swine flu’ vaccine
In 2009, Drs. Judith James and Linda Thompson at the Oklahoma Medical Research Foundation (OMRF) helped develop an…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Veterinary
Australia approved locally made bird flu vaccine
On Jun. 15, 2008, Australia announced it had approved the first locally made vaccine to protect humans from…
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | Pharmaceutical | Vaccine
Merck voluntarily recalled 12 million doses of Haemophilus influenzae type b
On Dec. 12, 2007, Merck voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due…
ACIP voted to recommend the use of FluMist
On Oct. 26, 2007, the Immunization Practices Advisory Committee (ACIP) voted to recommend the use of FluMist, the…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…